A practical reference on reference standard: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-11-01 and is reviewed periodically as new material appears.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
Jellyfish-form hydrozoans have evolved many times, including the Portuguese man-o' war, and the crystal jelly. In the evolution of sexual reproduction and origin of the sex chromosome: mammals, females have two copies of the X chromosome (XX) and males have one copy of the X and one copy of the Y chromosome (XY). In birds it is the opposite, with males have two copies of the Z chromosome (ZZ) and females have one copy of the Z and one copy of the W chromosome (ZW). Multicellular organisms arose independently in brown algae (seaweed and kelp), plants, animals, and fungi. Origins of teeth have happened at least two times. Winged flight is found in unrelated species: birds, bats (mammal), insects, pterosaur and Pterodactylus (reptiles). Flying fish do not fly, but are very good at gliding flight. Hummingbird, dragonfly and hummingbird hawk-moth can hover and fly backwards. Neuroglobins are found in vertebrate neurons, (deuterostomes), and are found in the neurons of unrelated protostomes, like photosynthesis acoel and jelly fish. Siphonophorae and Praya dubia resemble and act like jellyfish, but are Hydrozoa, a colony of specialized minute individuals called zooids. Salp, a chordate, also is very much like jellyfish, yet completely different. Eusociality colonies in which only one female (queen) is reproductive and all other are divided into a castes system, all work together in a coordinate system.
New England Centenarian Study Okinawa Centenarian Study Mortality of Centenarians via Princeton University (archived 16 February 2006) U.S. politicians who lived the longest via Political Graveyard (archived 11 January 2009) Noted Nonagenarians and Centenarians via Genarians.com Centenarian research and celebration via AdlerCentenarians.org Living Beyond 100 via International Longevity Center UK (archived 16 June 2017) Table of numbers of centenarians for select nations, 1960 and 1990 Archived 10 June 2008 at the Wayback Machine via Demogr.mpg.de Centenarians' Road Project website (archived 24 June 2007) Oldest People in Britain
"Cellulose" . Encyclopædia Britannica. Vol. 5 (11th ed.). 1911. Structure and morphology of cellulose by Serge Pérez and William Mackie, CERMAV-CNRS Cellulose, by Martin Chaplin, London South Bank University Clear description of a cellulose assay method at the Cotton Fiber Biosciences unit of the USDA. Cellulose films could provide flapping wings and cheap artificial muscles for robots – TechnologyReview.com
Sources: en.wikipedia.org
The Brazilian public health system, the Unified Health System (Sistema Único de Saúde – SUS), is managed and provided by all levels of government, being the largest system of this type in the world. On the other hand, private healthcare systems play a complementary role. Public health services are universal and offered to all citizens of the country for free. However, the construction and maintenance of health centers and hospitals are financed by taxes, and the country spends about 9% of its GDP on expenditures in the area. In 2021, Brazil had 2.1 doctors and 2.5 hospital beds for every 1,000 inhabitants. Despite all the progress made since the creation of the universal health care system in 1988, there are still several public health issues in Brazil. In 2023, infant (2.51%) and maternal mortality rates (197.3 deaths per 100,000 births) were still high. The number of deaths from noncommunicable diseases, such as cardiovascular diseases (151.7 deaths per 100,000 inhabitants) and cancer (72.7 deaths per 100,000 inhabitants), also has a considerable impact on the health of the Brazilian population. Finally, external but preventable factors such as car accidents, violence and suicide caused 14.9% of all deaths in the country. The Brazilian health system was ranked 125th among the 191 countries evaluated by the World Health Organization (WHO) in 2000.
=== Developmental factors === Various developmental factors may affect rates of obesity. Breastfeeding, for example, may protect against obesity in later life with the duration of breastfeeding inversely associated with the risk of being overweight later on. A child's body growth pattern may influence the tendency to gain weight. Researchers measured the standard deviation (SD [weight and length]) scores in a cohort study of 848 babies. They found that infants who had an SD score above 0.67 had catch up growth (they were less likely to be overweight) compared to infants who had less than a 0.67 SD score (they were more likely to gain weight). Additionally, breastfeeding for less than six months, compared to six months or more, has been shown to result in a higher growth rate and higher BMI at 18, 36, and 72 months of age. A child's weight may be influenced when he/she is only an infant. Researchers also did a cohort study on 19,397 babies from their birth until age seven and discovered that high-weight babies at four months were 1.38 times more likely to be overweight at seven years old compared to normal-weight babies. High-weight babies at the age of one were 1.17 times more likely to be overweight at age seven compared to normal-weight babies.
The accepted treatment for affected boys presenting with the cerebral childhood form of the disease is a bone marrow transplant, a procedure which carries significant risks. However, because most affected males will demonstrate adrenal insufficiency, early discovery and treatment of this symptom could potentially prevent complications and allow these patients to be monitored for other treatment in the future, depending on the progression of their disease. The Loes score is a rating of the severity of abnormalities in the brain found on MRI. It ranges from 0 to 34, based on a point system derived from the location and extent of disease and the presence of atrophy in the brain, either localized to specific points or generally throughout the brain. A Loes score of 0.5 or less is classified as normal, while a Loes score of 14 or greater is considered severe. It was developed by neuroradiologist Daniel J. Loes MD and is an important tool in assessing disease progression and the effectiveness of therapy.
Fire was used by the Lower Paleolithic hominins Homo erectus and Homo ergaster as early as 300,000 to 1.5 million years ago and possibly even earlier by the early Lower Paleolithic (Oldowan) hominin Homo habilis or by robust Australopithecines such as Paranthropus. However, the use of fire only became common in the societies of the following Middle Stone Age and Middle Paleolithic. Use of fire reduced mortality rates and provided protection against predators. Early hominins may have begun to cook their food as early as the Lower Paleolithic (c. 1.9 million years ago) or at the latest in the early Middle Paleolithic (c. 250,000 years ago). Some scientists have hypothesized that hominins began cooking food to defrost frozen meat, which would help ensure their survival in cold regions. Archaeologists cite morphological shifts in cranial anatomy as evidence for emergence of cooking and food processing technologies. These morphological changes include decreases in molar and jaw size, thinner tooth enamel, and decrease in gut volume. During much of the Pleistocene epoch, our ancestors relied on simple food processing techniques such as roasting. The Upper Palaeolithic saw the emergence of boiling, an advance in food processing technology which rendered plant foods more digestible, decreased their toxicity, and maximised their nutritional value. Thermally altered rock (heated stones) are easily identifiable in the archaeological record.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.